KIMBERLY BERKVAM: Open Payments
NPI 1730861956 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 18 payments from 8 companies in 2025. Trend: 2023 $19 · 2024 $249 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 9 | $308 |
| Amgen Inc. | 1 | $98 |
| Legend Biotech USA Inc. | 1 | $69 |
| GENZYME CORPORATION | 3 | $59 |
| Incyte Corporation | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
Products named: REZUROCK, BLINCYTO, CARVYKTI, SARCLISA, NIKTIMVO, TALVEY, BLENREP, Polivy.
Industry payments across PA — which companies pay providers there.
